Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 18, 2025.
ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.
ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1620 in its research report dated July 18, 2025.
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2430 in its research report dated July 11, 2025.
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 1690 in its research report dated May 26, 2025.
KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in its research report dated February 18, 2025.
KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated November 18, 2024.
ICICI Securities recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 1345 in its research report dated August 16, 2024.
Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated August 16, 2024.
KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated August 20, 2024.
KR Choksey is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1403 in its research report dated June 03, 2024.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 1050 in its research report dated May 27, 2024.
KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1266 in its research report dated April 05, 2024.
KR Choksey recommended Accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 984 in its research report dated February 22, 2024.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 580 in its research report dated May 22, 2023.
Prabhudas Lilladher recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 570 in its research report dated May 23, 2023.
Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 460 in its research report dated February 14, 2023.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 14, 2022.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 470 in its research report dated November 21, 2022.
Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 460 in its research report dated November 19, 2022.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 17, 2022.
KR Choksey recommended accumulate rating on Glenmark Pharma with a target price of Rs 433 in its research report dated August 16, 2022.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 440 in its research report dated August 16, 2022.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated August 12, 2022.